Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma

INTRODUCTION: Tavokinogene Telseplasmid Electroporation Therapy (TAVO) and Pembrolizumab therapy is being studied in subjects with immune checkpoint inhibitor (ICI) resistant melanoma. TAVO is a novel office-based local therapy shown to be effective in patients with advanced melanoma. The technique...

Descripción completa

Detalles Bibliográficos
Autores principales: Dollin, Yonatan, Rubin, Jason, Carvajal, Richard D., Rached, Helene, Nitzkorski, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708754/
https://www.ncbi.nlm.nih.gov/pubmed/33395852
http://dx.doi.org/10.1016/j.ijscr.2020.11.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708754/
https://www.ncbi.nlm.nih.gov/pubmed/33395852
http://dx.doi.org/10.1016/j.ijscr.2020.11.063

Ejemplares similares